Recommendations from the National Vaccine Advisory Committee: Standards for Adult Immunization Practice

Orenstein, Walter A.; Gellin, Bruce G.; Beigi, Richard H.; Despres, Sarah; LaRussa, Philip; Lynfield, Ruth; Maldonado, Yvonne; Morita, Julie; Mouton, Charles P.; Pisani, Amy; Rawlins, Wayne; Rothholz, Mitchel C.; Stenvig, Thomas E.; Tan, Litjen; Torres, Catherine; Viswanath, Kasisomayajula; Hetherington, Seth; Hosbach, Philip; Andrus, Jon Kim; Breidbart, Scott; Daum, Robert S.; Douglas, Charlene; Ehresmann, Kristen; Etkind, Paul; Jarris, Paul E.; Salisbury, David; Spika, John S.; Temte, Jonathan L.; Villaseño, Ignacio; Caserta, Vito; Church, Richard; Gruber, Marion F.; Mabry-Hernandez, Iris; Hill, Rick; Kelman, Jeffrey A.; Martinello, Richard A.; Mills, J. Rebecca; Mulach, Barbara; Schuchat, Anne; Shen, Angela K.; Stanek, S. A.; Bridges, Carolyn B.

doi:10.1177/003335491412900203

Cited by 162 publications

(83 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Providers should adhere to recommendations to vaccinate persons with CLD and to the National Vaccine Advisory Committee’s standards for adult immunization practices, which include assessing the vaccination status of patients at every visit, strongly recommending needed vaccines, and either administering vaccine or referring patient to providers who can immunize [37]. Employing evidence-based interventions such as standing orders and provider reminders could also increase opportunities to vaccinate this population [21].…”

Section: Discussionmentioning

confidence: 99%

Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease

Yue

Black

et al. 2018

Vaccine

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease

Yue

Black

et al. 2018

Vaccine

View full text Add to dashboard Cite

“…22,26,27 To increase vaccination coverage among senior adults, healthcare providers are encouraged to include vaccination status assessment, recommendation and offer of vaccination, or referral if vaccines that are needed are not available, as a routine in their practices. 28 …”

Section: Discussionmentioning

confidence: 99%

National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years

Williams

Harpaz

2017

American Journal of Preventive Medicine

View full text Add to dashboard Cite

Introduction Shingles (herpes zoster) causes substantial morbidity, especially among older adults. The shingles vaccine has been recommended for people aged ≥60 years since 2006. This study assessed recent shingles vaccination at national and state levels among adults aged ≥60 years. Methods The 2014 Behavioral Risk Factor Surveillance System data were analyzed in 2015 to assess shingles vaccination coverage among adults aged ≥60 years at national and state levels. Multivariable logistic regression and predictive marginal models identified factors independently associated with vaccination. Results Shingles vaccination coverage among adults aged ≥60 years was 31.8% (95% CI=31.4%, 32.2%). Among states, shingles vaccination coverage ranged from 17.8% (95% CI=15.8%, 20.0%) in Mississippi to 46.6% (95% CI=44.3%, 48.8%) in Vermont, with a median of 33.3%. Coverage was <25% in four states and >40% in nine states. For all states, coverage was significantly higher among non-Hispanic whites compared with non-white races except for Oregon, with coverage differences ranging from −33.2% in the District of Columbia to 0.9% in Oregon and a median of −16.0%. Characteristics independently associated with vaccination were age, race/ethnicity, sex, education, employment status, household income, region, perceived health status, health insurance status, personal healthcare provider, routine checkup status, and whether reporting that cost was a barrier to seeing a doctor. Conclusions Coverage varied dramatically by state. State-level comparisons may aid in designing tailored intervention programs through sharing of best practices. Strategies are needed to mitigate financial barriers for both provider and patients, improve awareness, and increase provider recommendation of the vaccine.

show abstract

“…Implementation of evidence-based programs are needed to improve Td and Tdap vaccination, and state immunization programs are encouraged to engage providers to implement interventions shown to be effective in increasing vaccination among adults. 23, 37–39 Additionally, the Affordable Care Act (ACA) program should also help to improve Td and Tdap vaccination coverage among adult populations. 40, 41 …”

Section: Discussionmentioning

confidence: 99%

National and State-Specific Td and Tdap Vaccination of Adult Populations

Ding

Liang

et al. 2016

American Journal of Preventive Medicine

View full text Add to dashboard Cite

Background For adults, the Advisory Committee on Immunization Practices (ACIP) recommends a single dose of tetanus, diphtheria and acellular pertussis vaccine (Tdap) followed by tetanus and diphtheria toxoids (Td) booster doses every 10 years thereafter. Purpose To assess recent Td and Tdap vaccination among adult populations. Methods The 2013 BRFSS data were analyzed in 2015 to assess Td and Tdap vaccination coverage among adults at national and state levels. Multivariable logistic regression and predictive marginal models were performed to identify factors independently associated with vaccination. Results Overall, national vaccination coverage among adults ≥18 years for Td was 57.5% and for Tdap was 28.9%. Among states, Td vaccination coverage ranged from 47.8% in Nevada to 73.1% in Minnesota, and Tdap coverage ranged from 17.7% in Mississippi to 47.6% in Minnesota. Characteristics independently associated with an increased likelihood of Tdap vaccination among adults ≥18 years were: younger age; being female; American Indian/Alaska Native (AIAN) race; being never married; higher education; not being in the workforce, reporting a household income ≥$75,000; living in the West or Midwest of the United States; reporting excellent, very good, good, or fair health; having health insurance; having a healthcare provider; having a routine checkup in the previous year; receipt of influenza vaccination in the previous year; and having ever received pneumococcal vaccination. Conclusions By 2013, Td and Tdap vaccination coverage were 57.5% and 28.9%, respectively. Coverage varied by state. Implementation of evidence-based programs are needed to improve Td and Tdap vaccination levels among adult populations.

show abstract

Recommendations from the National Vaccine Advisory Committee: Standards for Adult Immunization Practice

Cited by 162 publications

References 7 publications

Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease

Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease

National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years

National and State-Specific Td and Tdap Vaccination of Adult Populations

Contact Info

Product

Resources

About